“…5,21 On the other hand, in other studies, rates of 9.1% to 31% therapy termination were reported because of side effects. 6,7,10 In conclusion, this study does not support the findings of the Smith pilot study. 4 Amantadine therapy in CH-C patients may be effective for reducing biochemical markers, but not for the eradication of HCV RNA.…”